Misdiagnoses in prostate biopsy patients lead to $880M in healthcare costs On average, roughly one in every 200 patients undergoing a prostate biopsy are misdiagnosed due to their biopsy specimens ...

Although sextant biopsy is inadequate and the current reference standard involves a minimum of 12 cores, there is a point of diminishing returns regarding the numbers of cores. We published findings ...

Growing evidence indicates that more patients with favorable Grade Group 2 prostate cancer can be successfully managed with active surveillance and achieve acceptable oncologic outcomes, even if later ...

—Physicians surveyed for a new study said that reports generated by artificial intelligence (AI) were, with a few exceptions, accurate and complete. They could also be modified faster than writing an ...

Grade group 1 and ASAP on prostate biopsy predict future prostate cancer risk and should not be ignored. Prostate biopsy findings of Gleason grade group (GG) 1 or atypical small acinar proliferation ...

It's common for healthcare professionals to order biopsies for patients whom they suspect may have prostate cancer. A biopsy doesn't just rule out prostate cancer or show its presence, though. It can ...

Micro-ultrasound–guided biopsies were found for the first time to be “noninferior” to MRI-guided procedures, according to new research presented at the 2025 annual congress of the European Association ...

68 Ga-PSMA PET/MRI examples of PRIMARY scores. T2WI = T2-weighted image; PZ = peripheral zone; CZ = central zone. Reston, VA—PET/MRI can improve diagnostic accuracy for prostate cancer patients and ...

MRI of the prostate, combined with a blood test, can help determine if a prostate lesion is clinically significant cancer, new research suggests. A new meta-analysis by investigators from Brigham and ...